ABUS vs IP
Arbutus Biopharma Corp (ABUS) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
IP does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the ABUS and IP stock pages for the full models.
Not investment advice.